Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management.


Journal

The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 18 6 2019
medline: 19 3 2020
entrez: 18 6 2019
Statut: ppublish

Résumé

Detailed recommendations and guidelines for acute pancreatitis (AP) management currently exist. However, quality indicators (QIs) are required to measure performance in health care. The goal of the Acute Pancreatitis Task Force on Quality was to formally develop QIs for the management of patients with known or suspected AP using a modified version of the RAND/UCLA Appropriateness Methodology. A multidisciplinary expert panel composed of physicians (gastroenterologists, hospitalists, and surgeons) who are acknowledged leaders in their specialties and who represent geographic and practice setting diversity was convened. A literature review was conducted, and a list of proposed QIs was developed. In 3 rounds, panelists reviewed literature, modified QIs, and rated them on the basis of scientific evidence, bias, interpretability, validity, necessity, and proposed performance targets. Supporting literature and a list of 71 proposed QIs across 10 AP domains (Diagnosis, Etiology, Initial Assessment and Risk Stratification, etc.) were sent to the expert panel to review and independently rate in round 1 (95% of panelists participated). Based on a round 2 face-to-face discussion of QIs (75% participation), 41 QIs were classified as valid. During round 3 (90% participation), panelists rated the 41 valid QIs for necessity and proposed performance thresholds. The final classification determined that 40 QIs were both valid and necessary. Hospitals and providers managing patients with known or suspected AP should ensure that patients receive high-quality care and desired outcomes according to current evidence-based best practices. This physician-led initiative formally developed 40 QIs and performance threshold targets for AP management. Validated QIs provide a dependable quantitative framework for health systems to monitor the quality of care provided to patients with known or suspected AP.

Identifiants

pubmed: 31205135
doi: 10.14309/ajg.0000000000000264
doi:

Substances chimiques

Analgesics 0
Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1322-1342

Auteurs

Elaina Vivian (E)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Leslie Cler (L)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Darwin Conwell (D)

The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Gregory A Coté (GA)

Medical University of South Carolina, Charleston, South Carolina, USA.

Richard Dickerman (R)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Martin Freeman (M)

University of Minnesota, Minneapolis, Minnesota, USA.

Timothy B Gardner (TB)

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

Robert H Hawes (RH)

Institute for Minimally Invasive Therapy, Florida Hospital, Orlando, Florida, USA.

Prashant Kedia (P)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Rajesh Krishnamoorthi (R)

Virginia Mason Medical Center, Seattle, Washington, USA.

Hellen Oduor (H)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Stephen J Pandol (SJ)

Cedars-Sinai Medical Center, Los Angeles, California, USA.

Georgios I Papachristou (GI)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Andrew Ross (A)

Virginia Mason Medical Center, Seattle, Washington, USA.

Amrita Sethi (A)

Columbia University Medical Center, New York Presbyterian, New York, New York, USA.

Shyam Varadarajulu (S)

Center for Interventional Endoscopy, Florida Hospital, Orlando, Florida, USA.

Santhi Swaroop Vege (SS)

Mayo Clinic, Rochester, Minnesota, USA.

Wahid Wassef (W)

University of Massachusetts Memorial Medical Center, Worchester, Massachusetts, USA.

C Mel Wilcox (CM)

University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.

David C Whitcomb (DC)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Bechien U Wu (BU)

Kaiser Permanente Los Angeles, Los Angeles, California, USA.

Dhiraj Yadav (D)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Ashton Ellison (A)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Samar Habash (S)

AtlantiCare Regional Medical Center, Atlantic City, New Jersey, USA.

Sheila Rastegari (S)

AtlantiCare Regional Medical Center, Atlantic City, New Jersey, USA.

Rathan Reddy (R)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Timothy Yen (T)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Mary Rachel Brooks (MR)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Paul Tarnasky (P)

Methodist Dallas Medical Center, Dallas, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH